Home LiteratureArticle Details
PMID: 8592997 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Mutacin II, a bactericidal antibiotic from Streptococcus mutans.

Antimicrobial agents and chemotherapy ·Vol. 39 ·No. 12 ·1995-12-00 ·Pages 2656-60

Chikindas ML, Novák J, Driessen AJ, Konings WN, Schilling KM, Caufield PW

Abstract

Mutacin II is an antibiotic that is produced by group II Streptococcus mutans. It inhibits the growth of other streptococci as well as many other gram-positive microorganisms by a hitherto unknown mechanism. Mutacin II possess bactericidal activity against susceptible cells. It transiently depolarizes the transmembrane electrical potential (delta psi) and the transmembrane pH gradient (delta pH) and partially inhibits amino acid transport. However, it rapidly depletes the intracellular ATP pool in glucose-energized cells and prevents the generation of ATP. It is concluded that mutacin II does not belong to the group of pore-forming antibiotics (type A) or to the type B antibiotics, which inhibit phospholipases or interfere with peptidoglycan biosynthesis. Mutacin II acts by inhibiting essential enzyme functions at the level of metabolic energy generation, an activity that has not yet been classified for antibiotics.

MeSH Terms
Adenosine Triphosphate/metabolism Amino Acids/metabolism Bacteria/drug effects,metabolism Bacteriocins/biosynthesis,isolation & purification,pharmacology Energy Metabolism/drug effects Glucose/metabolism Hydrogen-Ion Concentration Membrane Potentials/drug effects Pyrans/pharmacology Streptococcus mutans/metabolism Surface-Active Agents/pharmacology
Chemicals
Amino Acids Bacteriocins Pyrans Surface-Active Agents cocolactobionamide Adenosine Triphosphate mutacin II Glucose
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Chikindas M L
Unilever Dental Research, United Kingdom.
Novák J
Driessen A J
Konings W N
Schilling K M
Caufield P W
References (21)
21 references, click to expand
  1. Bacteriocins from human and rodent streptococci.
    Arch Oral Biol. 1969 Mar;14(3):251-8 PMID: 4978137
  2. Production and properties of bacteriocins (mutacins) from Streptococcus mutans.
    Arch Oral Biol. 1975 Oct;20(10):641-8 PMID: 1059386
  3. Characteristics and energy requirements of an alpha-aminoisobutyric acid transport system in Streptococcus lactis.
    J Bacteriol. 1976 Aug;127(2):719-30 PMID: 8422
  4. A PVC-based electrode sensitive to DDA+ as a device for monitoring the membrane potential in biological systems.
    Arch Biochem Biophys. 1978 Apr 30;187(2):414-22 PMID: 666319
  5. Role of bacteriocin during plaque formation by Streptococcus salivarius and Streptococcus sanguis on a tooth in an artificial mouth.
    J Appl Bacteriol. 1981 Apr;50(2):305-13 PMID: 7251515
  6. Two plasmid-determined restriction and modification systems in Streptococcus lactis.
    Plasmid. 1984 May;11(3):260-3 PMID: 6087394
  7. Bioenergetic consequences of lactose starvation for continuously cultured Streptococcus cremoris.
    J Bacteriol. 1987 Apr;169(4):1460-8 PMID: 3558320
  8. Regulation of the glutamate-glutamine transport system by intracellular pH in Streptococcus lactis.
    J Bacteriol. 1987 May;169(5):2272-6 PMID: 3106334
  9. Neutral amino acid transport by membrane vesicles of Streptococcus cremoris is subject to regulation by internal pH.
    J Bacteriol. 1987 Jun;169(6):2748-54 PMID: 3108240
  10. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin.
    Arch Microbiol. 1987;149(2):120-4 PMID: 3442448
  11. The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes.
    Eur J Biochem. 1989 Jun 1;182(1):181-6 PMID: 2471644
  12. Bioenergetics and solute transport in lactococci.
    Crit Rev Microbiol. 1989;16(6):419-76 PMID: 2500949
  13. Studies of "BLIS-ful" oral bacteria.
    N Z Dent J. 1991 Jan;87(387):14-6 PMID: 2052207
  14. Continuous measurement of the cytoplasmic pH in Lactococcus lactis with a fluorescent pH indicator.
    Biochim Biophys Acta. 1991 Nov 14;1115(1):75-83 PMID: 1958707
  15. Purification and primary structure of pediocin PA-1 produced by Pediococcus acidilactici PAC-1.0.
    Arch Biochem Biophys. 1992 May 15;295(1):5-12 PMID: 1575516
  16. The efflux of a fluorescent probe is catalyzed by an ATP-driven extrusion system in Lactococcus lactis.
    J Bacteriol. 1992 May;174(10):3118-24 PMID: 1577684
  17. The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs.
    J Clin Periodontol. 1993 May;20(5):335-9 PMID: 8501273
  18. Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells.
    Appl Environ Microbiol. 1993 Nov;59(11):3577-84 PMID: 8285666
  19. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans.
    J Bacteriol. 1994 Jul;176(14):4316-20 PMID: 8021218
  20. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles.
    Biochemistry. 1995 Feb 7;34(5):1606-14 PMID: 7849020
  21. Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
    Eur J Biochem. 1995 Jun 15;230(3):827-53 PMID: 7601145
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1995-12-00
Pages
2656-60
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC163007
Subset
IM
Grants
NIDCR NIH HHS · R01 DE09082 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com